Raman Baweja is a Psychiatry physician affiliated with Penn State Milton S. Hershey Medical Center. OpenAlex indexes 169 publications with 2,596 citations (h-index 28); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
22 Northeast Dr
Hershey, PA 170332732
Telephone
717-531-8338Provider last certified this registry record 26 May 2021.
Clinical trials
- Neurophysiological Markers of Pediatric Irritability and Its Response to Intervention
Sponsor: Milton S. Hershey Medical Center
- Effects of Evening Dose of Immediate Release Methylphenidate on Sleep in Children With ADHD
Sponsor: Milton S. Hershey Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Collegium Pharmaceutical, Inc.Program year20251 payment
- Supernus Pharmaceuticals, Inc.Program year20251 payment
- Tris Pharma IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Mood Stabilizer100%Carbamazepine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care
Journal of Child and Adolescent Psychopharmacology
2024 - Systematic Review and Meta-analysis: Pharmacological and Nonpharmacological Interventions for Persistent Nonepisodic Irritability
Journal of the American Academy of Child & Adolescent Psychiatry
2022 - A Review of ADHD and Childhood Trauma: Treatment Challenges and Clinical Guidance
Current Developmental Disorders Reports
2022 - Updates in Pharmacologic Strategies for Emotional Dysregulation in Attention Deficit Hyperactivity Disorder
Child and Adolescent Psychiatric Clinics of North America
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Nancy Olsen, MD
Penn State Milton S. Hershey Medical Center
Michael Glantz, MD
Penn State Milton S. Hershey Medical Center
Joel Sorosky, MD
Penn State Milton S. Hershey Medical Center
Shin Mineishi, MD
Penn State Milton S. Hershey Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”